4 Insights on

• Improved Epithelial Permeability
• Reduced Enterotoxicity
• Reduced Toxin A-Receptor Binding
• Reduced Fluid Secretion in the Ileum

5 Insights on

• Reduced Duration of Diarrhea
• Improved Nonspecific Humoral Response
• Increased Specific IgA Levels to Rotavirus
• Accelerated Diarrhea Recovery
• Improved Specific IgA Response to Rotavirus

2 Insights on

• Reduced Colonic Inflammation
• Increased Peripheral Blood B Cell Frequency

3 Insights on

• Reduced Gastrointestinal Infections
• Increased Intestinal IgA Secretion
• Increased Intestinal Inflammatory Response

1 Insight on

• Septicemia Incidence

2 Insights on

• Improved Insulin Response
• Improved Glycogen Synthetase Activity

7 Insights on

• Enhanced Natural Killer Cell Tumoricidal Activity
• Reduced Serum Cholesterol Levels
• Improved Lactose Digestion
• Reduced Intestinal Infections
• Reduced Cancer Activity
• Prevention of Intestinal Infections
• Controlled Serum Cholesterol Levels

2 Insights on

• No Change in Diarrhea Development in C. difficile-Positive Patients
• No Adverse Effects

2 Insights on

• Reduced Tumor Growth
• Reduced Pulmonary Metastasis

1 Insight on

• Improved Phagocytic Activity

2 Insights on

• Reduced Serum Total Cholesterol Levels
• Reduced Serum Cholesterol

2 Insights on

• Increased Facultative Lactobacilli in Upper Small Intestines
• Prevention of Intestinal Infections

1 Insight on

• Reduced Fecal Bacterial Enzyme Activity

5 Insights on

• Improved Lactose Digestion
• Improved Lactose Tolerance
• Unchanged Lactose Utilization
• Unchanged Lactose Utilization at Intermediate Dosage
• No Significant Improvement in Lactose Utilization

1 Insight on

• Reduced Susceptibility to Bacterial Infection

3 Insights on

• Reduced Beta-Glucuronidase Activity
• Reduced Fecal Bacterial Enzyme Activity
• Reduced Fecal Bacterial Nitroreductase Activity

1 Insight on

• No Adverse Health Effects

2 Insights on

• Increased PMN Cell Phagocytic Capacity
• Improved Resistance to Chronic Infections

6 Insights on

• Reduced Neuroinflammation
• Increased Short-Chain Fatty Acid Production
• Improved Gut Integrity
• Improved Behavioral Health
• Reduced Gut Inflammation
• Reduced Repetitive Behaviors

10 Insights on

• Maintained General Health
• Non-Translocation to Blood or Organs
• Reduced Bacterial Translocation
• Increased Gut Lactobacillus plantarum Population
• Increased Bacterial Survival
• Enhanced Food Safety
• Maintained Morphological Integrity
• Increased Bacterial Translocation
• Stable Organ Weight
• No Negative Impact on Hematological Parameters

9 Insights on

• Improved Intestinal Barrier Function
• Reduced Body Weight
• Reduced Hepatic Oxidative Stress
• Reduced Inflammatory Response
• Reduced Intestinal Inflammation
• Improved Lipid Levels
• Reduced Oxidative Stress
• Reduced Histopathological Damage
• Reduced Histological Damage

7 Insights on

• Increased Fecal Lactobacilli
• Increased Short-Chain Fatty Acid Levels
• Increased Protease Activity
• Increased Lactobacilli Abundance
• Altered Short-Chain Fatty Acid Production
• Reversed Microbiome Metabolic Changes
• Restored Short-Chain Fatty Acid Levels

9 Insights on

• Improved Insulin Sensitivity
• Reduced Total Cholesterol Levels
• Reduced Blood Pressure
• Increased Beneficial Gut Microbiota
• Increased HDL Cholesterol Levels
• Reduced Harmful Gut Bacteria
• Enhanced Beneficial Bacteria in Intestinal Microbiota
• Reduced Harmful Bacteria in Intestinal Microbiota
• Attenuated Blood Pressure (Inactivated Cells Only)

8 Insights on

• Reduced Hepatic Oxidative Stress
• Reduced Pro-inflammatory Cytokine Levels
• Improved Inflammatory Response
• Reduced Oxidative Stress
• Enhanced Antioxidant Activity
• Enhanced Antioxidant Enzyme Activity
• Increased Lead Ion Adsorption
• Reduced Tissue Lead Levels

3 Insights on

• Increased Short-Chain Fatty Acid Production
• Reduced Acetate to Propionate Ratio
• Improved Gut Microbiome Composition

5 Insights on

• Reduced Pro-inflammatory Cytokine Levels
• Improved Colonic Histopathology
• Reduced Clostridium difficile Infection
• Improved Microbial Diversity
• Improved Colonic Histology

7 Insights on

• Reduced Pro-Inflammatory Cytokines
• Reduced Body Weight
• Improved Immune Function
• Improved Liver Function
• Reduced Inflammation Levels
• Improved Antimicrobial Ability
• Increased Intestinal Subepidermal CD4+ Cell Levels

4 Insights on

• Normalized Gut Microbiota
• Restored Intestinal Microbiota Balance
• Reduced Clinical Symptoms of Arthritis
• Maintained Fecal Short Chain Fatty Acid Levels

8 Insights on

• Improved Intestinal Barrier Function
• Reduced Intestinal Inflammation
• Improved Immunomodulation
• Improved Gastrointestinal Tolerance
• Reduced Nuclear Factor Kappa B Activation
• Improved Colonic Histopathology
• Improved Treg/Th-17 Balance
• Improved Intestinal Microenvironment

19 Insights on

• Reduced Cytotoxic Effects
• Reduced Pathogen Growth
• Improved Biochemical Parameters
• Reduced Cytotoxicity
• Stable Body Weight
• Reduced Foodborne Pathogens
• Prevented Significant Weight Loss
• Reduced Inflammation
• Maintained Weight
• Reduced Inflammatory Cell Activity
• Normalization of Blood Biochemical Parameters
• Reduced Pathogen Activity
• Reduced LPS-Induced Cellular Activity
• Prevention of Weight Loss
• Reduced Significant Weight Loss
• Reduced Pathogen-Induced Weight Loss
• Enhanced Stress Resistance
• Improved Serum Biochemistry
• Enhanced Gastrointestinal Survival